The neurotoxic effects of methylenedioxymethamphetamine (MDMA) and its metabolites on rat brain spheroids in culture

Cell Biology and Toxicology

Volumn 15, Issue 3, 1999, Pages 137-142

  Walker, T M ^a   Davenport Jones, J E ^b   Fox, R M ^b   Atterwill, C K ^c  

^a GLAXOSMITHKLINE   (United Kingdom)

^b UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

^c ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

Brain; Culture; Glutathione; MDMA; Neurotoxicity; Spheroids

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 6 HYDROXY 3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE DERIVATIVE; DIHYDROXYMETHAMPHETAMINE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; SEROTONIN; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FETUS; MOLECULAR DYNAMICS; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

3,4-METHYLENEDIOXYAMPHETAMINE; ANIMALS; BIOLOGICAL MARKERS; BRAIN; BRAIN DISEASES; CYTOSOL; DEOXYEPINEPHRINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FETUS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTATHIONE; L-LACTATE DEHYDROGENASE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; SEROTONIN; SEROTONIN AGENTS; SPHEROIDS, CELLULAR;

EID: 0032706399     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007658501306     Document Type: Article

References (21)

1. Atterwill CK, Purcell WM. Brain spheroid and other organotypic culture systems in in vitro neurotoxicicology. In: Pentreath W, ed. Neurotoxicology in vitro. Taylor and Francis, UK [In press].
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-54.
3. Chu T, Kumagai Y, Distefano EW, Cho AK. Disposition of methylenedioxymethamphetamine and three metabolites in the brains of different rat strains and their possible roles in acute serotonin depletion. Biochem Pharmacol. 1996;51: 789-96.
4. Commins DL, Vosmer G, Virus RM, Woolverton WL, Schuster CR, Seiden LS. Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther. 1987;241: 338-45.
5. Fox RM, Davenport-Jones JE, Atterwill CK. Gliotoxicity in brain reaggregate cultures caused by oxidants and excitatory amino acids can be prevented by α-tocopherol and MK-801. Neurotoxicology. 1996;17(4):705-10.
6. Frankfurt M, O'Callaghan J, Beaudet A. 5-7-Dihydroxytryptamine injections increase glial fibrillary acidic protein in the hypothalamus of adult rats. Brain Res. 1991;549:138-40.
7. Hiramatsu M, Kumagai Y, Unger SE, Cho AK. Metabolism of methylenedioxymethamphetamine: formation of dihydroxymethamphetamine and a quinone identified as its glutathione adduct. J Pharmacol Exp Ther. 1990;254:521-7.
8. Hissin PJ, Hilf R. A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem. 1976;74:214-26.
9. Honegger P, Schilter B. The use of serum-free aggregating brain cell cultures in neurotoxicology. In: Chang LW, Slikker W, eds. Neurotoxicology: approaches and methods. San Diego: Academic Press; 1995:507-16.
10. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods. 1983;64:313-20.
11. Lin LY, Kumagai Y, Cho AK. Enzymatic and chemical demethylenation of (methylenedioxy) amphetamine and (methylenedioxy) methamphetamine by rat brain microsomes. Chem Res Toxicol. 1992;5:401-6.
12. Miller RT, Lau SS, Monks TJ. 2,5-bis-(Glutathion-S-yl)-α-methylenedioxyamphetamine decreases brain serotonin concentrations. Eur J Pharmacol. 1997;323:172-80.
13. Moscona AA. Cell suspensions from organ rudiments of chick embryos. Exp Cell Res. 1952;3:535-9.
14. O'Callaghan JP. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci. 1991a; 4:197-206.
15. O'Callaghan JP. Quantification of glial fibrillary acidic protein: comparison of slot immunobinding assays with a novel sandwich ELISA. Neurotox Teratol. 1991b;13:275-81.
16. Schmidt CJ, Taylor VL. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. Eur J Pharmacol. 1988;156:121-31.
17. Schmidt CJ. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine. J Pharmacol Exp Ther. 1987;240:1-7.
18. Snyder SH, Axelrod J, Zweig M. A sensitive and specific fluorescence assay for tissue serotonin. Biochem Pharmacol. 1965;14:831-5.
19. Tucker GT, Lennard MS, Ellis SW et al. The demethylation of methylenedioxymethamphetamine ("Ecstasy") by debrisoquine hydroxylase (CYP2D6). Biochem Pharmacol. 1994; 47:1151-6.
20. Vanable J. A ninhydrin reaction giving a sensitive quantitative fluorescence assay for 5-hydroxytryptamine. Anal Biochem. 1963;6:393-403.
21. Zhao Z. Synthesis and neurotoxicological evaluation of putative metabolites of the serontonergic neurotoxin 2-(methylamino)-1, 1[3,4-(methylenedioxy)phenyl]propane [methylenedioxy) methamphetamine]. Chem Res Toxicol.1992;5:89-94.